(Q33334950)

English

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

Christoph Engel

object named as

C Engel

1

0 references

author name string

M Loeffler

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Schmitz

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Tesch

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Diehl

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1105-1114

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose optimisation and dose intensification in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008301225839

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008301225839

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33334950&oldid=1644630944"